Antibiotic Resistance Market Report: Trends, Forecast and Competitive Analysis to 2030

October 2023 | 150 pages | ID: A87D57A3E104EN
Lucintel

Abstracts

Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.

Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.

Contents

1. EXECUTIVE SUMMARY


2. GLOBAL ANTIBIOTIC RESISTANCE MARKET : MARKET DYNAMICS

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Antibiotic Resistance Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Antibiotic Resistance Market by Disease
  3.3.1: cUTI (Complicated Urinary Tract Infections)
  3.3.2: CDI (Clostridioides difficile Infection)
  3.3.3: ABSSSI (Acute bacterial skin and skin structure infections)
  3.3.4: HABP (Hospital-acquired bacterial pneumonia)
  3.3.5: CABP (Community-acquired pneumonia)
  3.3.6: cIAI (Complicated intra-abdominal infection)
  3.3.7: Others
3.4: Global Antibiotic Resistance Market by Pathogen
  3.4.1: E. coli
  3.4.2: K. pneumoniae
  3.4.3: P. aeruginosa
  3.4.4: S. aureus
  3.4.5: A. baumannii
  3.4.6: S. pneumoniae
  3.4.7: Others
3.5: Global Antibiotic Resistance Market by Distribution Channel
  3.5.1: Hospital Pharmacies
  3.5.2: Retail Pharmacies
  3.5.3: Online Pharmacies
3.6: Global Antibiotic Resistance Market by Mechanism of Action
  3.6.1: Protein Synthesis Inhibitors
  3.6.2: Cell Wall Synthesis Inhibitors
  3.6.3: RNA Synthesis Inhibitors
  3.6.4: DNA Synthesis Inhibitors
  3.6.5: Others

4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030

4.1: Global Antibiotic Resistance Market by Region
4.2: North American Antibiotic Resistance Market
  4.2.2: North American Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Antibiotic Resistance Market
  4.3.1: European Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
  4.3.2: European Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Antibiotic Resistance Market
  4.4.1: APAC Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
  4.4.2: APAC Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Antibiotic Resistance Market
  4.5.1: ROW Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
  4.5.2: ROW Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. COMPETITOR ANALYSIS

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS

6.1: Growth Opportunity Analysis
  6.1.1: Growth Opportunities for the Global Antibiotic Resistance Market by Disease
  6.1.2: Growth Opportunities for the Global Antibiotic Resistance Market by Pathogen
  6.1.3: Growth Opportunities for the Global Antibiotic Resistance Market by Distribution Channel
  6.1.4: Growth Opportunities for the Global Antibiotic Resistance Market by Mechanism of Action
  6.1.5: Growth Opportunities for the Global Antibiotic Resistance Market by Region
6.2: Emerging Trends in the Global Antibiotic Resistance Market
6.3: Strategic Analysis
  6.3.1: New Product Development
  6.3.2: Capacity Expansion of the Global Antibiotic Resistance Market
  6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antibiotic Resistance Market
  6.3.4: Certification and Licensing

7. COMPANY PROFILES OF LEADING PLAYERS

7.1: Melinta
7.2: Basilea Pharmaceutical
7.3: Tetraphase Pharmaceuticals
7.4: Theravance Biopharma
7.5: WOCKHARDT